Cris Loiren Rodriguez

Array ( [id] => 4726651 [patent_doc_number] => 20080206192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Combination Therapy' [patent_app_type] => utility [patent_app_number] => 12/112452 [patent_app_country] => US [patent_app_date] => 2008-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22926 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20080206192.pdf [firstpage_image] =>[orig_patent_app_number] => 12112452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4710603 [patent_doc_number] => 20080299129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'ANTAGONISTS TO IL-17A, IL-17F, AND IL-23P19 AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/111117 [patent_app_country] => US [patent_app_date] => 2008-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50231 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20080299129.pdf [firstpage_image] =>[orig_patent_app_number] => 12111117 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4718608 [patent_doc_number] => 20080241130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'METHODS AND COMPOSITIONS FOR MODULATING IL-17F/IL-17A BIOLOGICAL ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/057778 [patent_app_country] => US [patent_app_date] => 2008-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 34007 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20080241130.pdf [firstpage_image] =>[orig_patent_app_number] => 12057778 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 32673 [patent_doc_number] => 07790676 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-07 [patent_title] => 'Soluble IL-17RA/RC fusion proteins' [patent_app_type] => utility [patent_app_number] => 12/055597 [patent_app_country] => US [patent_app_date] => 2008-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 79312 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/790/07790676.pdf [firstpage_image] =>[orig_patent_app_number] => 12055597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4839332 [patent_doc_number] => 20080279817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Treatment of Autoimmune Diseases and Allograft Rejection with IL-21' [patent_app_type] => utility [patent_app_number] => 12/052787 [patent_app_country] => US [patent_app_date] => 2008-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13085 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20080279817.pdf [firstpage_image] =>[orig_patent_app_number] => 12052787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6320187 [patent_doc_number] => 20100196310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'METHODS OF TREATING CANCER BY ADMINISTERING HUMAN IL-18 COMBINATIONS' [patent_app_type] => utility [patent_app_number] => 12/532776 [patent_app_country] => US [patent_app_date] => 2008-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 14596 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20100196310.pdf [firstpage_image] =>[orig_patent_app_number] => 12532776 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4859060 [patent_doc_number] => 20080267910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Rat, rabbit, and cynomolgus monkey IL-21 and IL-22 nucleotide and polypeptide sequences' [patent_app_type] => utility [patent_app_number] => 12/073707 [patent_app_country] => US [patent_app_date] => 2008-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 12820 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20080267910.pdf [firstpage_image] =>[orig_patent_app_number] => 12073707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4853092 [patent_doc_number] => 20080318835 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'Novel Integrin Ligand ITGL-TSP' [patent_app_type] => utility [patent_app_number] => 12/040449 [patent_app_country] => US [patent_app_date] => 2008-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9452 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20080318835.pdf [firstpage_image] =>[orig_patent_app_number] => 12040449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6245623 [patent_doc_number] => 20100135998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'COMBINATION THERAPY FOR TREATMENT OF IMMUNE DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/527459 [patent_app_country] => US [patent_app_date] => 2008-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 22053 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20100135998.pdf [firstpage_image] =>[orig_patent_app_number] => 12527459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6412707 [patent_doc_number] => 20100166767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'ENGINEERED ANTI-IL-23R ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/526544 [patent_app_country] => US [patent_app_date] => 2008-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22108 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20100166767.pdf [firstpage_image] =>[orig_patent_app_number] => 12526544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4697811 [patent_doc_number] => 20080219995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'IL-32 MONOCLONAL ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/032298 [patent_app_country] => US [patent_app_date] => 2008-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13153 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20080219995.pdf [firstpage_image] =>[orig_patent_app_number] => 12032298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4751910 [patent_doc_number] => 20080159983 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'Interleukin-15 antagonists for the treatment of anemia' [patent_app_type] => utility [patent_app_number] => 12/005767 [patent_app_country] => US [patent_app_date] => 2007-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9200 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20080159983.pdf [firstpage_image] =>[orig_patent_app_number] => 12005767 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7790487 [patent_doc_number] => 20120052043 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-01 [patent_title] => 'Chemokine-Chaperone Fusion Proteins' [patent_app_type] => utility [patent_app_number] => 12/519430 [patent_app_country] => US [patent_app_date] => 2007-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3898 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20120052043.pdf [firstpage_image] =>[orig_patent_app_number] => 12519430 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6220013 [patent_doc_number] => 20100055108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'DRUG FOR TREATING GASTRIC CANCER' [patent_app_type] => utility [patent_app_number] => 12/312774 [patent_app_country] => US [patent_app_date] => 2007-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8804 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20100055108.pdf [firstpage_image] =>[orig_patent_app_number] => 12312774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5495373 [patent_doc_number] => 20090263401 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE' [patent_app_type] => utility [patent_app_number] => 11/957994 [patent_app_country] => US [patent_app_date] => 2007-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8466 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20090263401.pdf [firstpage_image] =>[orig_patent_app_number] => 11957994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4753464 [patent_doc_number] => 20080161540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'IL-17A/F heterologous polypeptides and therapeutic uses thereof' [patent_app_type] => utility [patent_app_number] => 11/953733 [patent_app_country] => US [patent_app_date] => 2007-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 62318 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20080161540.pdf [firstpage_image] =>[orig_patent_app_number] => 11953733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5992551 [patent_doc_number] => 20110014204 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'Cancer Chemoprevention Strategy Based on Loss of Imprinting of IGF2' [patent_app_type] => utility [patent_app_number] => 12/446735 [patent_app_country] => US [patent_app_date] => 2007-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 31018 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20110014204.pdf [firstpage_image] =>[orig_patent_app_number] => 12446735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4692491 [patent_doc_number] => 20080085262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-10 [patent_title] => 'PURIFIED MAMMALIAN CYTOKINES; RELATED REAGENTS AND METHODS' [patent_app_type] => utility [patent_app_number] => 11/952802 [patent_app_country] => US [patent_app_date] => 2007-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26452 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20080085262.pdf [firstpage_image] =>[orig_patent_app_number] => 11952802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4746391 [patent_doc_number] => 20080090993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-17 [patent_title] => 'PURIFIED MAMMALIAN CYTOKINES; RELATED REAGENTS AND METHODS' [patent_app_type] => utility [patent_app_number] => 11/952779 [patent_app_country] => US [patent_app_date] => 2007-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26429 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20080090993.pdf [firstpage_image] =>[orig_patent_app_number] => 11952779 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4751948 [patent_doc_number] => 20080160021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'IL-17 HOMOLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF' [patent_app_type] => utility [patent_app_number] => 11/949633 [patent_app_country] => US [patent_app_date] => 2007-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 72 [patent_figures_cnt] => 72 [patent_no_of_words] => 75599 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20080160021.pdf [firstpage_image] =>[orig_patent_app_number] => 11949633 [rel_patent_id] =>[rel_patent_doc_number] =>)